Back to Search
Start Over
Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.
- Source :
-
Stroke [Stroke] 2006 Jul; Vol. 37 (7), pp. 1923-32. Date of Electronic Publication: 2006 Jun 01. - Publication Year :
- 2006
-
Abstract
- Background and Purpose: The simplistic view of atherosclerosis as a disorder of pathological lipid deposition has been redefined by the more complex concept of an ongoing inflammatory response.<br />Summary of Review: Apolipoprotein E and low-density lipoprotein (LDL)-receptor-deficient mice develop accelerated atherosclerosis allowing in-depth pathophysiological investigations. Atherosclerotic plaques in these mice contain large numbers of T cells and macrophages. Crossbreeding apolipoprotein E-deficient mice with T-cell-deficient mice and mice with impaired macrophage function (osteopetrotic op/op mice) disclosed the important impact of immune cells on atherosclerotic lesion development. In contrast to the detrimental role of T cells and macrophages, B cells appear to be atheroprotective. These basic experimental findings have partly been confirmed in studies of the human carotid artery system. Inflammation is not only instrumental in the development of human atheromatous plaques, but, importantly, plays a crucial role in the destabilization of internal carotid artery plaques, thus converting chronic atherosclerosis into an acute thrombo-embolic disorder. Humoral factors involved in internal carotid artery destabilization include cytokines, cyclooxygenase-2, matrix metalloproteinases, and tissue factor. Antibodies to oxidized LDL can reflect disease activity on one hand, but can also confer atheroprotection. Novel MRI techniques may aid in the in vivo assessment of acute plaque inflammation in humans.<br />Conclusions: The impact of inflammation on the development of atherosclerotic plaques and their destabilization opens new avenues for treatment. The effects of statins, acetylsalicyclic acid and angiotensin-converting enzyme inhibitors on stroke prevention may partly be attributable to their profound anti-inflammatory actions. Vaccination against modified LDL and heat shock proteins halt plaque progression in experimental atherosclerosis. Their potential for prevention of human atherosclerosis is currently under investigation.
- Subjects :
- Animals
Anti-Inflammatory Agents therapeutic use
Apolipoproteins E deficiency
Apolipoproteins E genetics
Atherosclerosis immunology
Atherosclerosis physiopathology
Autoantibodies immunology
Carotid Artery Diseases complications
Carotid Artery Diseases drug therapy
Carotid Artery Diseases pathology
Crosses, Genetic
Cytokines antagonists & inhibitors
Cytokines physiology
Endothelium, Vascular injuries
Endothelium, Vascular metabolism
Endothelium, Vascular physiopathology
Female
Heart Transplantation
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use
Inflammation drug therapy
Lipoproteins, LDL immunology
Macrophages pathology
Magnetic Resonance Imaging
Male
Mice
Mice, Knockout
Mice, SCID
Models, Animal
Osteopetrosis genetics
Osteopetrosis immunology
Postoperative Complications immunology
Postoperative Complications pathology
Protease Inhibitors therapeutic use
Receptors, LDL deficiency
Receptors, LDL genetics
Severe Combined Immunodeficiency genetics
Severe Combined Immunodeficiency immunology
Stroke etiology
Stroke prevention & control
T-Lymphocytes pathology
Thromboembolism etiology
Thromboembolism prevention & control
Vaccination
Vasculitis complications
Vasculitis drug therapy
Vasculitis physiopathology
Atherosclerosis etiology
Inflammation complications
Subjects
Details
- Language :
- English
- ISSN :
- 1524-4628
- Volume :
- 37
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Stroke
- Publication Type :
- Academic Journal
- Accession number :
- 16741184
- Full Text :
- https://doi.org/10.1161/01.STR.0000226901.34927.10